B R Murphy

3.0k total citations
44 papers, 2.5k citations indexed

About

B R Murphy is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, B R Murphy has authored 44 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Epidemiology, 9 papers in Infectious Diseases and 9 papers in Immunology. Recurrent topics in B R Murphy's work include Influenza Virus Research Studies (30 papers), Respiratory viral infections research (28 papers) and Animal Virus Infections Studies (7 papers). B R Murphy is often cited by papers focused on Influenza Virus Research Studies (30 papers), Respiratory viral infections research (28 papers) and Animal Virus Infections Studies (7 papers). B R Murphy collaborates with scholars based in United States. B R Murphy's co-authors include M L Clements, Bernard Moss, Robert F. Betts, E L Tierney, M L Clements, Geoffrey L. Smith, Gregory A. Prince, R M Chanock, R. M. Chanock and N Elango and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and The Journal of Immunology.

In The Last Decade

B R Murphy

43 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B R Murphy United States	28	2.1k	842	668	326	249	44	2.5k
Julie Furze United Kingdom	23	1.3k 0.6×	783 0.9×	737 1.1×	239 0.7×	464 1.9×	27	2.2k
E L Tierney United States	26	1.8k 0.9×	704 0.8×	587 0.9×	120 0.4×	291 1.2×	37	2.2k
Judy A. Beeler United States	32	2.1k 1.0×	1.0k 1.2×	723 1.1×	222 0.7×	203 0.8×	60	2.9k
M. W. Brandriss United States	25	1000 0.5×	1.2k 1.4×	333 0.5×	155 0.5×	193 0.8×	44	2.3k
E. H. Lennette United States	25	1.1k 0.5×	818 1.0×	306 0.5×	331 1.0×	412 1.7×	72	2.3k
David C. Flyer United States	24	659 0.3×	795 0.9×	714 1.1×	192 0.6×	336 1.3×	45	1.9k
Eugene B. Buynak United States	27	2.0k 0.9×	773 0.9×	530 0.8×	223 0.7×	340 1.4×	62	2.5k
E. J. Stott United States	36	3.0k 1.4×	1.8k 2.1×	831 1.2×	461 1.4×	331 1.3×	108	4.3k
John F. Enders United States	34	1.7k 0.8×	1.0k 1.2×	691 1.0×	818 2.5×	536 2.2×	84	3.4k
D. Neumann‐Haefelin Germany	29	1.3k 0.6×	538 0.6×	373 0.6×	590 1.8×	452 1.8×	84	2.4k

Countries citing papers authored by B R Murphy

Since Specialization

Citations

This map shows the geographic impact of B R Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B R Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B R Murphy more than expected).

Fields of papers citing papers by B R Murphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B R Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B R Murphy. The network helps show where B R Murphy may publish in the future.

Co-authorship network of co-authors of B R Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of B R Murphy. A scholar is included among the top collaborators of B R Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B R Murphy. B R Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Crowe, James E., Phuong Bui, Mark Connors, et al.. (1996). Live Subgroup B Respiratory Syncytial Virus Vaccines that Are Attenuated, Genetically Stable, and Immunogenic in Rodents and Nonhuman Primates. The Journal of Infectious Diseases. 173(4). 829–839. 49 indexed citations

Moldoveanu, Zina, M L Clements, S J Prince, B R Murphy, & Jiří Městecký. (1995). Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine. 13(11). 1006–1012. 153 indexed citations

Karron, Ruth A., Peter F. Wright, Susan L. Hall, et al.. (1995). A Live Attenuated Bovine Parainfluenza Virus Type 3 Vaccine Is Safe, Infectious, Immunogenic, and Phenotypically Stable in Infants and Children. The Journal of Infectious Diseases. 171(5). 1107–1114. 111 indexed citations

Hall, Susan L., et al.. (1993). A Cold-Adapted Mutant of Parainfluenza Virus Type 3 Is Attenuated and Protective in Chimpanzees. The Journal of Infectious Diseases. 167(4). 958–962. 26 indexed citations

Edwards, Kathryn M., James C. King, M. C. Steinhoff, et al.. (1991). Safety and Immunogenicity of Live Attenuated Cold-Adapted Influenza BlAnn Arbor/1/86 Reassortant Virus Vaccine in Infants and Children. The Journal of Infectious Diseases. 163(4). 740–745. 43 indexed citations

Murphy, B R, Gregory A. Prince, Peter W. Collins, S HILDRETH, & Peter R. Paradiso. (1991). Effect of passive antibody on the immune response of cotton rats to purified F and G glycoproteins of respiratory syncytial virus (RSV). Vaccine. 9(3). 185–189. 26 indexed citations

Steinhoff, M. C., N. A. Halsey, Mark H. Wilson, et al.. (1990). Comparison of Live Attenuated Cold-Adapted and Avian-Human Influenza A/Bethesda/85 (H3N2) Reassortant Virus Vaccines in Infants and Children. The Journal of Infectious Diseases. 162(2). 394–401. 49 indexed citations

Murphy, B R, et al.. (1989). Immunosuppression of the Antibody Response to Respiratory Syncytial Virus (RSV) by Pre-existing Serum Antibodies: Partial Prevention by Topical Infection of the Respiratory Tract with Vaccinia Virus-RSV Recombinants. Journal of General Virology. 70(8). 2185–2190. 27 indexed citations

Olmsted, Robert A., R. Mark L. Buller, Peter W. Collins, et al.. (1988). Evaluation in non-human primates of the safety, immunogenicity and efficacy of recombinant vaccinia viruses expressing the F or G glycoprotein of respiratory syncytial virus. Vaccine. 6(6). 519–524. 39 indexed citations

10.

Elango, N, Gregory A. Prince, B R Murphy, et al.. (1986). Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein.. Proceedings of the National Academy of Sciences. 83(6). 1906–1910. 97 indexed citations

11.

Brown, Thomas A., B R Murphy, J Rádl, J.J. Haaijman, & Jiří Městecký. (1985). Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans. Journal of Clinical Microbiology. 22(2). 259–264. 97 indexed citations

12.

Clements, M L, E L Tierney, & B R Murphy. (1985). Response of seronegative and seropositive adult volunteers to live attenuated cold-adapted reassortant influenza A virus vaccine. Journal of Clinical Microbiology. 21(6). 997–999. 18 indexed citations

13.

Clements, M L, Robert F. Betts, & B R Murphy. (1984). A/ワシントン/80(H3N2)wild-typeウイルス感染における減弱性cold-adaptedインフルエンザAウイルス生ワクチンの不活化ワクチンに対する優位性. The Lancet. 1(8379). 705–708. 37 indexed citations

14.

Clements, M L, S O'Donnell, Myron M. Levine, Robert M. Chanock, & B R Murphy. (1983). Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus. Infection and Immunity. 40(3). 1044–1051. 108 indexed citations

15.

Tolpin, Mark D., M L Clements, Myron M. Levine, et al.. (1982). Evaluation of a phenotypic revertant of the A/Alaska/77-ts-1A2 reassortant virus in hamsters and in seronegative adult volunteers: further evidence that the temperature-sensitive phenotype is responsible for attenuation of ts-1A2 reassortant viruses. Infection and Immunity. 36(2). 645–650. 20 indexed citations

16.

Tyrrell, D. A. J., G. C. Schild, W. R. Dowdle, R M Chanock, & B R Murphy. (1981). Development and use of influenza vaccines.. Bulletin of the World Health Organization. 59(2). 165–173. 8 indexed citations

17.

Murphy, B R & R M Chanock. (1979). Present status of live influenza A virus vaccine.. PubMed. 11. 1–20. 1 indexed citations

18.

London, W. T., et al.. (1978). Experimental production of respiratory tract disease in cebus monkeys after intratracheal or intranasal infection with influenza A/Victoria/3/75 or influenza A/New Jersey/76 virus. Infection and Immunity. 21(1). 201–205. 10 indexed citations

19.

Maassab, H. F., et al.. (1977). Cold-adapted variants of influenza virus A. Virology. 77(1). 337–343. 23 indexed citations

20.

Richman, Douglas D., B R Murphy, W. Lee Cline, & David W. Alling. (1975). Determination of influenzavirus neuraminidase inhibition titres.. PubMed. 52(2). 233–4. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact